Search

everythinglearnresearchcommunity

for

Search:↓

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Tamoxifen caused hair loss in a 52-year-old woman.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Hair loss gene linked to prostate issues.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

The scalp lotion helped increase hair thickness in cancer patients undergoing chemotherapy.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Anti-angiogenic drugs do not worsen COVID-19 severity in lung cancer patients.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.